ArticleBiomaterials research2024

Targeting miR-21 to Overcome P-glycoprotein Drug Efflux in Doxorubicin-Resistant 4T1 Breast Cancer.

Eun Hye Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.